These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4588193)

  • 1. Inactivated rabies vaccine produced from the Flury LEP strain of virus grown in BHK-21 suspension cells.
    Chapman WG; Ramshaw IA; Crick J
    Appl Microbiol; 1973 Dec; 26(6):858-62. PubMed ID: 4588193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inactivated rabies vaccine, produced from a cell culture. Preliminary results].
    Branche R; Lang R; Petermann HG; Soulebot JP
    Prog Immunobiol Stand; 1967; 3():144-50. PubMed ID: 4908593
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
    Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
    J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
    Pay TW; Boge A; Menard FJ; Radlett PJ
    Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of rabies virus inactivated by -propiolactone, acetylethyleneimine, and ionizing irradiation.
    Wiktor TJ; Aaslestad HG; Kaplan MM
    Appl Microbiol; 1972 May; 23(5):914-8. PubMed ID: 5031561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
    Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ
    Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabies antibody determination by immunofluorescence in tissue culture.
    Debbie JG; Andrulonis JA; Abelseth MK
    Infect Immun; 1972 Jun; 5(6):902-4. PubMed ID: 4628958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.
    Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW
    Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rabies in dogs experimentally infected with street virus and immunized with Flury LEP virus thereafter (author's transl)].
    Weinhold E; Scholz M; Leuchte S
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):288-95. PubMed ID: 4150062
    [No Abstract]   [Full Text] [Related]  

  • 10. Reproducible plaquing system for rabies, lymphocytic choriomeningitis,k and other ribonucleic acid viruses in BHK-21-13S agarose suspensions.
    Sedwick WD; Wiktor TJ
    J Virol; 1967 Dec; 1(6):1224-6. PubMed ID: 4987176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of the strain Flury HEP after its adaptation to cell culture. Development of experimental vaccine for veterinary use].
    Benmansour A
    Arch Inst Pasteur Alger; 1978-1979; 53():262-73. PubMed ID: 262969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified live-virus rabies vaccine produced from flury high egg-passage virus grown on an established canine-kidney cell line: three-year duration-of-immunity study in dogs.
    Brown AL; Merry DL; Beckenhauer WH
    Am J Vet Res; 1973 Nov; 34(11):1427-32. PubMed ID: 4748726
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.
    Kallel H; Jouini A; Majoul S; Rourou S
    J Biotechnol; 2002 May; 95(3):195-204. PubMed ID: 12007860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of rabies strain ("Pasteur Potsdam") adapted to primary dog kidney cells.
    Egert J; Apitzsch L; Triquart B; Sinnecker H
    Acta Virol; 1989 Dec; 33(6):553-8. PubMed ID: 2483605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
    Kallel H; Rourou S; Majoul S; Loukil H
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adaptation of a fixed rabies virus to monkey kidney cells. Use of this virus for the preparation of an inactivated anti-rabies vaccine].
    Lang R; Petermann HG; Branche R; Soulebot JP
    C R Acad Hebd Seances Acad Sci D; 1969 Dec; 269(22):2287-90. PubMed ID: 4983278
    [No Abstract]   [Full Text] [Related]  

  • 17. Some characteristics of persistent rabies virus infection in cell cultures.
    Suzuki M; Ohtani S; Oya A
    Asian J Infect Dis; 1979 Mar; 3(1):19-26. PubMed ID: 496710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency of two rabies vaccines in cats as determined by antibody assay and virulent virus challenge.
    Kihm U; Lazarowicz M; Bommeli W; Zutter R
    Comp Immunol Microbiol Infect Dis; 1982; 5(1-3):227-32. PubMed ID: 7128076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ultrastructural and immunofluorescent study of rabies virus in tissue culture for antiviral drug evaluation.
    Hernández-Jáuregui P; González-Vega D; Hernández-Baumgarten EM
    Arch Invest Med (Mex); 1981; 12(2):213-24. PubMed ID: 7023412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
    Moore SM; Ricke TA; Davis RD; Briggs DJ
    Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.